VOGX (VOGX) Stock Price & Analysis
VOGX (VOGX) fell 1.31% to USD 31.73 as of September 8, 2026 at 12:15 UTC, according to Nexqual real-time market data.
VOGX last closed at USD 32.15; the session ranged USD 31.63–34 on volume of 89,617 shares. Market capitalization is $471.35M, with a 52-week range of USD 12.95–35.5 (NCM). Source: Nexqual, September 8, 2026 at 12:15 UTC.
Key Statistics (as of September 8, 2026 at 12:15 UTC)
| Price | USD 31.73 |
|---|---|
| Change | ▼ 1.31% (down) |
| Previous Close | USD 32.15 |
| Open | USD 32.12 |
| Day Range | USD 31.63 – 34 |
| 52-Week Range | USD 12.95 – 35.5 |
| Volume | 89,617 shares |
| Market Cap | $471.35M |
| Exchange | NCM |
Analyst Ratings (VOGX)
Wall Street analysts rate VOGX "None", per Nexqual as of September 8, 2026 at 12:15 UTC.
| Consensus Rating | None |
|---|
Earnings (VOGX)
Source: Nexqual, September 8, 2026 at 12:15 UTC.
Financials & Fundamentals (VOGX)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Current Ratio | 0.39 |
| Total Cash | $250,753 |
| Total Debt | $835,800 |
Source: Nexqual, September 8, 2026 at 12:15 UTC.
Financial Health Score (VOGX)
Nexqual rates VOGX's overall financial health "Weak" across five dimensions, as of September 8, 2026 at 12:15 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Mixed — $251K cash, no debt |
| Cash Flow | Weak — Operating cash flow -$1M |
| Efficiency | Mixed — No data |
Ownership (VOGX)
| Insider Ownership | +4.74% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 14.86M |
| Float | 3.35M |
Source: Nexqual, September 8, 2026 at 12:15 UTC.
Leadership (VOGX)
VOGX is led by James Green (age 56), President, CEO & Chairman, per Nexqual as of September 8, 2026 at 12:15 UTC.
| President, CEO & Chairman | James Green (age 56) |
|---|---|
| CFO, Corporate Secretary & Director | Steven R. Delmar (age 69) |
| Chief Scientific Officer, Chair of Scientific Advisory Board & Director | William Wilkison (age 65) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| LTGO | Latigo Biotherapeutics, Inc. | USD 23.04 | ▲ 5.83% |
| BRVE | Braveheart Bio, Inc. | USD 26.74 | ▼ 0.78% |
| COAG | Hemab Therapeutics Holdings, In | USD 44.41 | ▼ 0.65% |
| SCTX | Scribe Therapeutics Inc. | USD 28.67 | ▼ 7.22% |
| ODTX | Odyssey Therapeutics, Inc. | USD 28.76 | ▲ 8.04% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 12:15 UTC. This page is informational and not investment advice.